SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001078782-20-000898
Filing Date
2020-11-20
Accepted
2020-11-20 15:16:35
Documents
1
Period of Report
2020-11-16
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 1.02: Termination of a Material Definitive Agreement
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 2.02: Results of Operations and Financial Condition
Item 4.02: Non-Reliance on Previously Issued Financial Statements or a Related Audit Report or Completed Interim Review
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 PHOENIX LIFE SCIENCES INTERNATIONAL LIMITED. (FORM: 8-K, RECEIVED: 08/29/2019 16 f8k111620_8k.htm 8-K 32370
  Complete submission text file 0001078782-20-000898.txt   34288
Mailing Address 3000 LAWRENCE STREET DENVER CO 80205
Business Address 3000 LAWRENCE STREET DENVER CO 80205 1.720.699.7222
Phoenix Life Sciences International Limited. (Filer) CIK: 0001493212 (see all company filings)

IRS No.: 460525378 | State of Incorp.: NV | Fiscal Year End: 0228
Type: 8-K | Act: 34 | File No.: 000-56064 | Film No.: 201332123
SIC: 2833 Medicinal Chemicals & Botanical Products